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NucleocapsidDuring tRNALys3 annealing in HIV-1, tRNALys3 binds to both the primer binding site (PBS) and to an 8
nucleotide base-paired sequence upstream of the PBS known as the primer activation signal (PAS). In
protease-negative (Pr(−)) HIV-1, the amount of tRNALys3 annealed by Gag is 35% less than that annealed by
mature nucleocapsid (NCp7) in protease-positive (Pr(+)) virions. Gag-annealed tRNALys3 also has a reduced
ability to initiate reverse transcription, and binds less tightly to viral RNA than NCp7-annealed tRNALys3.
Pr(−) virions containing a constitutively single-stranded PAS (2R mutant), show a signiﬁcant increase in the
ability to initiate reverse transcriptionwith little change in the amount of tRNALys3 annealed. However, the 2R
mutant does not achieve levels of RT initiation achieved in Pr(+) virions, and tRNALys3 binding to viral RNA
remains weak. Wild type levels of initiation and tRNALys3 binding to viral RNA can only be recovered by
transient exposure of Pr(−) or Pr(−)2R viral RNA to NCp7. This suggests that in addition to facilitating
annealing of tRNALys3 to the PBS and possible denaturation of the PAS, other functions of NCp7 involved in
annealing are required. The effect of an inactive protease and/or the 2R mutation upon tRNALys3 annealing
and initiation are also observed when the tRNALys3 is annealed in vitro to wild type or mutant viral RNA using
either NCp7 or GagΔp6, indicating a direct effect of the 2R mutation upon tRNALys3 annealing.© 2009 Elsevier Inc. All rights reserved.Introduction
In HIV-1, minus-strand viral DNA synthesis by reverse transcrip-
tase is initiated by a cellular tRNA, tRNALys3, which binds to sequences
in the 5′ region of the viral RNA genome (Kleiman, Halwani, and
Javanbakht, 2004). These sequences include the primer binding site
(PBS), an 18 nucleotide (nt) sequence complementary to the 3′
terminal 18 nt of tRNALys3, as well as additional sequences upstream of
the PBS within the U5-leader stem/loop domain. For example, an A-
rich loop located upstream and adjacent to the PBS has been
postulated to interact with the tRNALys3 anti-codon loop (Isel et al.,
1995, 1993), although a later paper from that group seems to indicate
that this interaction may be unique to the unusual HIV-1 MAL isolate
(Goldschmidt et al., 2004). Another sequence discovered in U5 region
further upstream from the PBS is an 8 nt sequence termed the primer
activation signal (PAS), that is complementary to the 5′ portion of theted at Lady Davis Institute for
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ll rights reserved.TΨC arm in tRNALys3, referred to as the anti-PAS in Fig. 1 (Beerens and
Berkhout, 2002b; Beerens et al., 2001). Mutations within this region
have revealed that the PAS has little effect upon the amount of
tRNALys3 annealed, but is important for activating initiation of reverse
transcription from the annealed tRNA (Beerens and Berkhout, 2002b;
Beerens et al., 2001). The PAS in the U5 region is normally base-paired
with complementary RNA sequences in the leader region, and in vitro
studies have shown that while mutating the PAS leads to an inhibition
of reverse transcription initiation, mutating the complementary
strand so as to result in a single-stranded PAS results in a large
increase in the initiation of reverse transcription (Beerens et al., 2001).
The PAS motif has been shown to be conserved among all HIV-1
isolates (Beerens and Berkhout, 2002a), and a similar interaction
between a U5 motif in Rous sarcoma virus and the TΨC arm in this
virus' primer tRNA, tRNATrp, has been reported earlier (Leis et al.,
1993; Morris et al., 2002).
It has been suggested that regulating the availability of the PAS for
hybridizing to tRNALys3 may be a mechanism for preventing
premature initiation of reverse transcription during viral assembly,
i.e., initiation of reverse transcription may require denaturation of the
base-paired PAS (Abbink and Berkhout, 2008). There may also be
other structural arrangements of viral RNA required to make the PAS
available for annealing to tRNALys3, since it has been reported that
Fig. 1. The tRNALys3/viral genomic RNA interaction. Model for the interaction between the U5/PBS/leader sequence in the 5′ region of viral genomic RNA (A) and tRNALys3 (B). In
addition to the interaction between the PBS and anti-PBS, an additional interaction is proposed to occur between the upstream primer activation signal (PAS) and sequences in the 5′
part of the TΨC arm in tRNALys3 (Beerens and Berkhout, 2002b; Beerens et al., 2001). Interacting sequences are boxed. (C). The 2Rmutation. 7 nt in the right strand complementary to
the PAS region are substituted with sequences identical to the PAS region, thereby resulting in non-base-paired sequences in the PAS.
335J. Saadatmand et al. / Virology 391 (2009) 334–341sequences downstream of the PBS can play a role in inﬂuencing the
availability of the PAS for annealing (Ooms et al., 2007).
Earlier studies have indicated that in protease-negative (Pr(−))
HIV-1, Gag is sufﬁcient for annealing tRNALys3 to the viral RNA (Cen
et al., 1999; Feng et al., 1999). However, the placement of tRNALys3 on
viral RNA is not optimal, since extension of annealed tRNALys3 by
addition of the ﬁrst deoxyribonucleotide triphosphate (dNTP), dCTP,
was reduced by N70% compared to +1 extension of tRNALys3 in
protease-positive (Pr(+)) virions (Cen et al., 2000). In this work, we
provide additional evidence that Gag-annealed tRNALys3 binds more
weakly to viral RNA than NCp7-annealed tRNALys3 by showing that
tRNALys3 annealed by Gag is more readily displaced from the PBS by
DNA reverse transcribed from a DNA primer downstream of the PBS.
It is possible that the increased ability of annealed tRNALys3 to
initiate reverse transcription in Pr(+) viruses may be due to NCp7-
facilitated increases in the availability of the PAS to anneal with
tRNALys3, changes that could involve both denaturation of the PAS and
structural changes elsewhere in the RNA. In this work, we haveexamined the effect upon tRNALys3 annealing and initiation of reverse
transcription in Pr(−) virions containing a constitutively single-
stranded PAS, and demonstrate that a single-stranded PAS will result
in increases in the initiation of reverse transcription, but cannot
achieve wild type levels of annealing and initiation achieved by
transient exposure of Pr(−) viral RNA to NCp7.
Results
Effect of the 2R mutation upon viral genomic RNA and tRNALys3
incorporation, tRNALys3 annealing, and initiation of reverse transcription
The primer activation signal (PAS) was ﬁrst described by
Berkhout's laboratory (Beerens and Berkhout, 2002b; Beerens et al.,
2001). As shown in Fig. 1A, the PAS represents an 8 base sequence
lying upstream of the PBS that is normally double-stranded, and
which is complementary to an 8 base sequence in the 5′ portion of the
TΨC arm in tRNALys3, termed the anti-PAS (Fig. 1B). Evidence has been
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from reverse transcription from the tRNALys3 primer, without
signiﬁcantly increasing the amount of tRNALys3 annealed (Beerens
and Berkhout, 2002b; Beerens et al., 2001). The 2Rmutation shown in
Fig. 1C is created by replacing sequences in the right strand
complementary to the PAS with identical sequences to the PAS,
thereby producing a constitutively single-stranded PAS. This mutation
in Pr(+) virions was previously reported to result in signiﬁcant
increase in initiation of reverse transcription in vitro (Beerens et al.,
2001). Since tRNALys3 annealed by NCp7 in Pr(+) virions also shows
an increase in the ability to initiate reverse transcription compared to
tRNALys3 annealed by Gag in Pr(−) virions (Cen et al., 2000), we have
determined if this is a result of denaturation of the PAS by NCp7 by
examining the effect of the 2R mutation on annealing and initiation in
Pr(−) viruses.
293T cells were transfected with plasmids coding for Pr(+) or
Pr(−) HIV-1, which did, or did not, contain the 2Rmutation. The effect
of the 2R mutation on the viral genomic RNA/CAp24 were compared
separately for Pr(+) and Pr(−) virions because of different
sensitivities of anti-CAp24 to mature CAp24 vs capsid sequences
within Gag. The results shown in the table in Fig. 2A indicate that the
2R mutation has a very minor effect upon viral RNA packaging in
either Pr(+) or Pr(−) viruses. When dot blots of total viral RNA were
annealed with 3′-32P-end-labeled DNA probes complementary toFig. 2. tRNALys3 incorporation and initiation of reverse transcription in protease-positive an
were produced from 293Tcells cotransfected with a plasmid coding for BH10 (Pr+) or BH10P
the 2R mutation on the viral genomic RNA/CAp24 was compared separately for Pr(+) and Pr
tRNALys3/viral genomic RNA ratios in virions were determined by dot blot hybridization of t
little if any change in the incorporation of viral RNA or tRNALys3 into viruses as a result of th
tRNALys3/genomic RNA complex, with the 6 nt extension produced by reverse transcriptase u
by 1D PAGE of the 6 nt extension products of tRNALys3. Amounts of extension product, relativ
30 nt DNA oligomer primer annealed at room temperature to the viral RNA, acting as a contr
tRNALys3. Right upper panel: Resolution by 1D PAGE of the 1 nt extension products of tRNAeither viral genomic RNA or tRNALys3, the results shown in the table in
Fig. 2A indicate little if any change in the incorporation of tRNALys3 into
viruses as a result of either the protease or 2R mutations.
Initiation of reverse transcription was measured in an in vitro
reverse transcription assay that extends the tRNALys3 by 6 nt, using
total viral RNA as the source of primer tRNALys3 annealed to viral RNA
in vivo (see the cartoon in Fig. 2B). tRNALys3 was extended by 6 bases in
the presence of excess dNTPs, including α-32P-dGTP, with ddATP
replacing dATP. In Fig. 2C, we have examined the effect of the 2R
mutation upon tRNALys3-primed initiation of reverse transcription in
both Pr(+) and Pr(−) virions. Fig. 2C, left upper panel, shows the 1D
PAGE resolution of radioactive reaction products. The +6 nt extension
of tRNALys3 from different viruses, relative to that obtained for (Pr+)
virions, is graphed in Fig. 2C, left lower panel. (Pr+) 2R produces a
small increase in extension over (Pr+). (Pr−) shows a signiﬁcant
decrease in priming ability (65% of (Pr+)), while the 2R mutant in
(Pr−) increases priming ability to 87% of (Pr+). These +6 extension
reactions contain equal amounts of genomic RNA, as initially
determined by dot blot hybridization. To further determine that the
variation in tRNALys3 priming is not due to variation in the amounts of
viral genomic RNA used, equal amounts of viral genomic RNA, as
determined from dot blot hybridizations, were also tested for their
ability to extend by 6 nt a 30 mer DNA oligomer primer annealed at
room temperature to the viral RNA (see Materials and methodsd protease-negative HIV-1, lacking or containing the 2R mutation. Four types of virions
− (Pr−), with or without the 2Rmutation. Total viral RNAwas isolated. (A) The effect of
(−) virions because of different sensitivities of anti-CAp24 tomature CAp24 vs Gag. The
otal viral RNA with a probe speciﬁc for either viral RNA or tRNALys3. The results indicate
e 2R mutations. (B–D) Relative initiation of reverse transcription. (B) A cartoon of the
nderlined. G⁎= α-32P-GMP. (C) 6 nt extension of tRNALys3. Left upper panel: Resolution
e to (Pr+), are graphed in the left lower panel. Left middle panel: 6 nt extension from a
ol to test for variable input of viral RNA in the reactions. (D) One nt (dCTP) extension of
Lys3. Amounts, relative to (Pr+), are graphed in the right lower panel.
Fig. 3. Measurements of the occupancy of the primer binding site by tRNALys3 in
protease-positive and protease-negative HIV-1, lacking or containing the 2R mutation.
Total viral RNA from Pr(+) or Pr(−) virions, containing or not containing the 2R
mutation, were used to determine primer binding site occupancy by tRNALys3.
(A) Cartoon showing the strategy used to measure the percentage of the PBSs occupied
with tRNALys3. A 5′-32P end-labeled DNA primer (28 nt) was annealed 139 bases
downstream of the PBS in viral RNA, and extended with reverse transcription. The full-
length extension product is 365 nt, while a truncated product, resulting from blocked
extension by the presence of tRNALys3 on the PBS, is 167 nt. (B) Separation of the full-
length and truncated extension products by 1D PAGE. The ratio of truncated product:
truncated and full-length product, ×100 = the percentage of PBSs occupied by
tRNALys3, which is listed at the bottom of each lane.
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amounts of viral RNA in the reaction, as determined by dot blot
hybridization, produce equal amounts of DNA-primed extension
products, and demonstrates that the variations in tRNALys3 priming
seen in the upper left panel are not due to variation in the amount of
viral RNA used.
As we have previously reported (Cen et al., 2000), the +6 nt
extension assay contains an excess of dNTPs which hides more subtle
differences in the ability of tRNALys3 to initiate reverse transcription
when annealing of the tRNALys3 has occurred in either a protease-
negative or protease-positive environment. Such differences can be
detected when the ﬁrst dNTP incorporated, dCTP, is present at
suboptimal quantities in the reverse transcription assay. This is
shown in Fig. 2D, in which the initiation of reverse transcription is
measured using total viral RNA as the source of primer/template, and
which occurs in the presence of only one dNTP, 0.16 μM α-32P-dCTP.
Fig. 2D shows the 1D PAGE resolution of tRNALys3 extended by one
base in the in vitro reverse transcription system (upper right panel),
and a graph of the amount of dCTP incorporation relative to Pr(+)
(lower right panel). The ability of protease-negative viruses to
incorporate dCTP is reduced to less than 20% of that found for viral
RNA from protease-positive viruses. The presence of a constitutively
denatured PAS (2R mutation) in either Pr(+) or Pr(−) virions greatly
increases the ability of the tRNALys3 to be extended by one base, with
almost a 2 fold increase for Pr(+)2R over that in Pr(+), and a 5 fold
increase for Pr(−)2R over that found for Pr(−). It is not clear why the
2R mutation induces the large increase in +1 nt extension in Pr(+)
viruses, but this may be due to an incomplete denaturation of the PAS
in Pr(+). The increase in +1 extension in Pr(−)2R does not reach
wild type (Pr(+)) levels.
tRNALys3 annealing measured by the primer binding site occupancy assay
The question remains whether these increases in initiation of
reverse transcription (either +6 nt or +1 nt extension) caused by the
2R mutation are the results of an increase in the amount of tRNALys3
annealed or an optimization of tRNALys3 placement on the viral RNA
genome. We examined this using the PBS occupancy assay, the results
of which are shown in Fig. 3. This assay more directly measures
tRNALys3 annealing by determining the fraction of primer binding sites
(PBSs) occupied by tRNALys3. A cartoon of the experimental strategy is
shown in Fig. 3A. A 5′-32P-end-labeled DNA primer (28 nt) is annealed
to a sequence in total viral RNA 139 nt downstream of the PBS, and is
then extended with HIV-1 RT. Full length extension will give a labeled
365 nucleotide product, but tRNALys3 annealed at the PBS will block
extension, resulting in a 167 nucleotide product. Resolution of these
products by 1D PAGE is shown in Fig. 3B, with the percentage of the
PBSs that are occupied (167 nucleotide product/167+365 nucleotide
products) listed below each lane.
In Pr(+) viruses, PBS occupancy is 79%. This value may be
considered a minimum value since we do not know if the block to
elongation by tRNALys3 annealed to the PBS is 100% efﬁcient. On the
other hand, since we have previously shown in an in vitro tRNALys3
annealing system that PBS occupancy is only 1% when tRNALys3 is
absent in a system containing both synthetic viral RNA and NCp7 (Guo
et al., 2007), it is not likely that an unoccupied PBS is in a conﬁguration
that can partially block RT elongation. The value of the PBS occupancy
in Pr(+) 2R, relative to that found in Pr(+), indicates that the 2R
mutation has a small negative effect upon PBS occupancy in Pr(+)
virions. Therefore, the large 2R-induced increase in initiation of
reverse transcription seen in Fig. 2D is not due to an increase in the
amount of tRNALys3 annealed, but more likely due to more optimal
placement of the tRNALys3 on the viral genome that allows for more
efﬁcient initiation. This conclusion is similar to that reached
previously by the Berkhout laboratory (Beerens and Berkhout,
2002b; Beerens et al., 2001).The +6 nt extension data seen in Fig. 2C suggests that the amount
of tRNALys3 annealed to viral RNA isolated from Pr(−) viruses is 65%
that of the value found in Pr(+) virions, and that the much
lower +1 nt extension (18% that of the value found in Pr(+) virions
(Fig. 2D)) may therefore be due to a non-optimal placement of the
annealed tRNALys3 on the viral RNA that lessens its ability to
incorporate the ﬁrst nucleotide, dCTP. This proposed weaker binding
of tRNALys3 to viral RNA in protease-negative viruses is also supported
by measurements of PBS occupancy in protease-negative viruses. For
while the amount of annealed tRNALys3 may only be reduced 35% in
protease-negative virions (Fig. 2C), the amount annealed as measured
by the PBS occupancy assay is reduced 76%, suggesting that the
tRNALys3 annealed in Pr(−) virions is more readily displaced by the
extension from the downstream DNA primer than is annealed
tRNALys3 in Pr(+) virions. This reduction in occupancy is not
inﬂuenced by the presence or absence of the 2R mutation, i.e., while
the 2R mutation causes a signiﬁcant increase in the ability of tRNALys3
to be extended by dCTP (Fig. 2D), the tRNALys3 placement on the viral
RNA still appears weak.Rescue of tRNALys3 annealing and initiation by transient exposure of
Pr(−) viral RNA to NCp7
Since NCp7 might affect tRNALys3 conformation in other ways, we
next determined if this apparent weaker binding of tRNALys3 to RNA
from Pr(−) or Pr(−)2R virions could be rescued by transient
exposure to NCp7. These results are shown in Fig. 4. Total viral RNAs
isolated from Pr(+), Pr(+)2R, Pr(−), or Pr(−)2R were transiently
exposed to increasing concentrations of NCp7, and further depro-
teinized before using the RNA in the reverse transcription reaction.
Fig. 4A shows that exposure to increasing concentrations of NCp7
Fig. 4. Optimization of tRNALys3 annealing in (Pr+) or Pr(−) viruses, containing or not
containing the 2R mutation, after transient exposure of the annealed complex to NCp7.
Total viral RNA isolated from Pr(+) or Pr(−) viruses, containing or not containing the
2R mutation, were transiently exposed to 3 different amounts of NCp7 (0, 4, and
10 pmol), followed by deproteinization. (A) One nt (dCTP) extension of tRNALys3. Shown
in the upper panel are the resolution by 1D PAGE of the 1 nt extension products of
tRNALys3, with the quantitation graphically present in the lower panel, relative to (Pr+)
viruses. (B) Occupancy of the primer binding site by tRNALys3. As described for Fig. 3, a
5′-32P-end-labeled DNA primer (28 nt) was annealed 139 bases downstream of the PBS
in viral RNA, and extended with reverse transcription. Resolution of the truncated and
full-length extension products are shown, with the percentage of PBSs occupied by
tRNALys3 listed at the bottom of each lane.
Fig. 5. Effect of the 2R mutation in viral RNA upon the in vitro annealing of tRNALys3 to
viral RNA by either NCp7 or GagΔp6. Puriﬁed human placental tRNALys3 and synthetic
viral RNA, wild type (WT) or containing the 2R mutation, was incubated with either
NCp7 or GagΔp6 as described in Materials and methods. The resulting tRNALys3/viral
RNA complex was then deproteinized, and used as a source of primer/template in the in
vitro reverse transcription system, where the tRNALys3 was extended by either +6 (A)
or+1 (B) nt, as described inMaterials andmethods. Quantitation of the results, relative
to wild type viral RNA, is presented in the lower part of each panel.
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for either Pr(+) or Pr(+)2R, which is to be expected since RNA
from both viral types has already been exposed to NCp7 in vivo. On
the other hand, transient exposure of viral RNA from Pr(−) or
Pr(−)2R, which were not exposed to NCp7 in vivo, does result in
increases of +1 initiation to levels achieved in Pr(+) and Pr(+)2R
viruses, respectively.
Furthermore, upon exposure to NCp7 of viral RNA from Pr(−)
virions (containing or not containing the 2R mutation), NCp7 rescues
PBS occupancy (Fig. 4B). Thus, while the 2R mutation is unable is
prevent tRNALys3 from being displaced in the PBS occupancy assay,
transient exposure to NCp7 appears to strengthen tRNALys3 binding to
viral RNA.
Effects of the 2R mutation upon annealing and initiation of reverse
transcription from tRNALys3 annealed by GagΔp6 or NCp7 in vitro
The data obtained using Pr(+) and Pr(−) assumes that the 2R
mutation is having its effect upon NCp7-annealed and Gag-annealed
tRNALys3, respectively. To show this directly, we examined the effect of
the 2Rmutation upon initiation of reverse transcription from tRNALys3
annealed in vitro by either Gag or NCp7. The results shown in Fig. 5 are
very similar to what we ﬁnd for tRNALys3 annealed in vivo. In Fig. 5,
puriﬁed tRNALys3 is annealed to synthetic viral RNA using either NCp7
or GagΔp6, and the ability of tRNALys3 to be extended by either 6 nt (A)
or 1 nt (B) is examined. Figs. 5A, B show that the +6 or +1 nt
extensions of tRNALys3 are signiﬁcantly reduced when tRNALys3 is
annealed by Gag compared to annealing facilitated by NCp7, and thatthe 2R mutation improves initiation of reverse transcription from
tRNALys3 annealed by either GagΔp6 or NCp7. The patterns seen in
Fig. 5 are very similar to those obtained using total viral RNA isolated
from 2R mutants in Pr(+) or Pr(−) viruses as the source of tRNALys3
annealed in vivo (Figs. 2C, D), and show a direct relationship between
the PAS in the viral RNA and the ability of annealed tRNALys3 to initiate
reverse transcription. And, as with tRNALys3 annealed in vivo, the 2R
mutation is not sufﬁcient to rescue initiation to wild type levels.
Discussion
In this work, the ability of annealed tRNALys3 to initiate reverse
transcription is studied using two reaction conditions that will allow
either a 6 nt extension or a 1 nt extension of annealed tRNALys3.
Measurements of the 6 nt extension reveal the amount of tRNALys3
annealed, since under the conditions used, the concentrations of all
dNTPs (including the α-32P-GTP used) are not limiting for the +6
extension (Cen et al., 2000). Furthermore, in Pr(+) virions, relative
changes in tRNALys3 binding resulting from the 2R mutation are
similar whether measured by the +6 nt extension or the PBS
occupancy assay. In the conditions for the +1 nt extension, used to
measure different conﬁgurations of annealed tRNALys3, we have
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maximum 1 nt extension of tRNALys3, which requires ≥5.0 μM dCTP,
and equal amounts of tRNALys3 annealed in Pr(+) and Pr(−) viruses
show different abilities to incorporate dCTP (Cen et al., 2000). The fact
that the increases in both +6 and +1 nt extension caused by the 2R
mutation (Fig. 2) do not correlate with the lack of change in binding
ability of tRNALys3 observed using the PBS occupancy assay (Fig. 3)
might indicate that the extension and occupancy data are not
quantitatively comparable. But this is unlikely based upon published
data on the effect of APOBEC3G (A3G) on the NCp7-catalyzed
annealing of tRNALys3 to viral RNA in vitro (Guo et al., 2007). In that
report, we showed that the presence of A3G in virions reduced +6
extension 70–80%, and PBS occupancy 80–84%. Furthermore, A3G
reduces the amount of 32P-tRNALys3 annealed by NCp7 in vitro 55%.
Thus, all three assays give similar results.
On the other hand, experiments rescuing +1 nt extension by
either NCp7 or the 2R mutation most likely reﬂect changes in the
conﬁguration of tRNALys3 annealed to viral RNA. Thus, we have
previously shown that the changes in +1 nt initiation of reverse
transcription due to exposure of Pr(−) RNA to NCp7 is not the result of
an increased binding of tRNALys3 to the viral RNA (Cen et al., 2000). It
was shown in that work that the addition of NCp7 to total viral RNA
isolated from Pr(−) virus does not result in any change in either
+6 nt extension, or in +1 nt extension using 5.0 μMdCTP. For while it
was shown in that paper that 0.16 μM dCTP is suboptimal for RT
initiation, both 5.0 μM dCTP (+1 nt extension) and the NTP
concentrations used during +6 nt extension are optimal, and these
NTP concentrations appear to be able to overcome conﬁgurational
changes that can only be detected by using suboptimal concentrations
of dCTP.
Therefore, another explanation must be sought for why the
denaturation of the PAS (2R mutation) can cause increased initiation
in Pr(−) viruses (though not reaching Pr(+) levels), and still not
change the ability of tRNALys3 to bind more stongly to viral RNA,
something only accomplished by exposure of RNA to NCp7. The
answer may be that the ability of tRNALys3 to capture the ﬁrst dCTP is
not a complete measure of the conﬁgurational state of tRNALys3
annealed to viral RNA, and the ability of annealed tRNALys3 to be
displaced may be a more sensitive measure of optimal conﬁguration.
The ability of NCp7, and not the 2R mutation, to rescue this
conﬁguration could be due to one or more possibilities. First, the
conﬁguration of the PAS denatured by mutations that produce an
identical anti-PAS strand may not be the same as the wild type PAS
sequences denatured by NCp7. Second, in addition to the possible
role of NCp7 in facilitating annealing to the largely, if not entirely,
single-stranded PBS through promoting nucleation, a denaturation of
the PAS by NCp7 might also require NCp7-facilitated RNA conforma-
tion changes downstream of the PBS that would be important for
regulating the availability of the PAS for annealing to tRNALys3 (Ooms
et al., 2007). Third, NCp7 has been reported to play a role in blocking
the interaction between the TΨC and D loops of tRNALys3, which
would result in a destabilization of the tertiary structure of tRNALys3,
which might also help promote optimum annealing (Hargittai et al.,
2001; Tisne et al., 2001).
While both the in vivo and in vitro works reported here indicate
that the effects of the 2R mutation upon tRNALys3 annealing and
initiation are direct, mutations in this region of viral RNA may also
have additional effects upon other processes in HIV-1 replication.
Thus, even though the 2R mutation in wild type viruses results in a
modest increase in the initiation of reverse transcription, it has
nevertheless been reported that the 2R mutation causes a 50–55%
reduction in the production of protease-positive HIV-1 (CAp24)
from transfected C33A cells (Beerens and Berkhout, 2002b). We
have also found that the 2R mutation produces a similar reduction
viral production in transfected 293T cells producing either Pr(+)2R
or Pr(−)2R virions (data not shown). It may be that a strictregulation of reverse transcription initiation is important for overall
viral replication, or perhaps the wild type anti-PAS sequence
mutated here is required for binding cell factors required for
viral production.
Materials and methods
Plasmids
BH10 is a simian virus 40-based vector that contains full-length
wild type BH10 strain of HIV-1 proviral DNA (termed Pr(+) viruses),
while BH10P− contains an inactive viral protease (D25G), and
produces Pr(−) viruses. BH102R and BH10P-2R constructs were
generated by mutating the region containing the “right” sequences
that are complementary to the PAS sequence in the stem 2 of the U5-
leader stem in HIV-1 viral RNA genome (see Fig. 1). A NarI–SpeI DNA
fragment (DNA nucleotide positions 637 to 1511) of HIV-1, encom-
passing the 5′-PBS, leader and the 5′-end of the gag gene, was PCR
ampliﬁed from BH10P− using the following two primers containing
SalI and SpeI sites, respectively: psvk forward PAS 5′-TAATTTGTC-
GACGGCGCCCGAACAGGGACCTGAAAGCG-3′and psvk reverse PAS 5′-
GC GGCGACTAGTAGTTCCTGCCTATGTCATTCC-3′. This fragment was
then cloned into the SalI and SpeI sites in pSVK3 plasmid (Amersham).
This NarI–SpeI fragment in pSVK3 subclone was used to construct the
2R mutation in a pSVK3 background using an in vitro site directed
mutagenesis kit (Stratagene) and using the following two HPLC
puriﬁed primers: forward 2R: 5′-GACCTGAAAGCGAAAGG-
GAATGGTCTCGAGCTCTCTCGACGCAGGAC-3′; Reverse 2R: 5′-GTCCTG-
CGTCGAGAGAGCTCGAGACCATTCCCTTTCGCTTTCAGGTC-3′. The 2R
mutation was veriﬁed by sequencing using the following primer:
psvk forward 5′-GTAATG TGGCTACCAGAAAATGTAAATTCG-3′. Subse-
quently, the mutated NarI–SpeI fragment containing the 2R mutation
was then excised from pSVK3 using NarI and SpeI, and was
reintroduced into either BH10 or BH10P− backgrounds generating
BH102R and BH10P-2R. The ﬁnal clones were veriﬁed by sequencing
using the following primer: PAS forward 5′-GGGAG CTCTCTGGCTAAC-
TAGGGAACCC-3′.
Protein production
HIV-1 RT, puriﬁed from bacteria as previously described (Huang
et al., 1996), was a gift from Matthias Gotte (McGill University).
Recombinant wild type NCp7 was a gift from R. Gorelick, and was
prepared as previously described (Carteau et al., 1999; Guo et al.,
2002), including puriﬁcation by reverse-phase high-pressure liquid
chromatography after denaturing the protein in 8 M guanidine
hydrochloride. GagΔp6 was a gift from A. Rein, and was prepared
as previously described (Cen et al., 2000). GagΔp6 was used
because it is easier to purify than full-length Gag, its assembly
properties in vitro have been characterized (Campbell and Rein,
1999), and it can efﬁciently facilitate annealing of tRNALys3 to viral
RNA (Feng et al., 1999).
Cells, transfections and virus puriﬁcation
HEK-293T cells were grown in complete Dulbecco's modiﬁed
Eagle's medium plus 10% fetal bovine serum, 100 U of penicillin, and
100 μg of streptomycin/ml. For the production of viruses, HEK-293T
cells were transfected using Lipofectamine 2000 (Invitrogen, Carls-
bad, California) according to the manufacturer's instruction. Super-
natant was collected 48 h post-transfection. Viruses were pelleted
from culture medium by centrifugation in a Beckman Ti-45 rotor at
35,000 rpm for 1 h. The viral pellets were then puriﬁed by 15% sucrose
onto a 65% sucrose cushion. The band of puriﬁed virus was removed
and pelleted in 1× TNE (20 mM Tris, pH 7.8, 100 mM NaCl, 1 mM
EDTA) in a Beckman Ti-45 rotor at 40,000 rpm for 1 h.
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Total viral RNA was extracted from viral pellets using the
guanidinium isothiocyanate procedure as previously described in
Huang et al. (1994) and was dissolved in 5 mM Tris buffer, pH 7.5. As
previously described (Cen et al., 2000), hybridization to dot blots of
total viral RNA was carried out with 5′-32P-end-labeled DNA probes
complementary to either the 3′-terminal 18 nucleotides of tRNALys3
(5′-TGGCGCCCGAACAGGGAC-3′), or to the 5′ end of the HIV-1 geno-
mic RNA, just upstream of the PBS (5′-CTGACGCTCTCGCACCC-3′). In
addition to dot blot analysis for determining the amount of viral RNA
used in each RT reaction mixture, the relative amounts of viral RNA in
the reaction mixtures were also determined by measuring the ability
of a 30-mer DNA (complementary to BH10 DNA nucleotides 801-830
(5′-TCTAATTCT CCCCCGCTTAATACTGACGCT-3′) annealed at room
temperature to the viral RNA to prime synthesis of a 6-base deoxy-
nucleotide triphosphate extension, using the same reaction condi-
tions as for measuring tRNALys3 priming, as previously described
(Guo et al., 2007).
tRNALys3-primed initiation of reverse transcription
Total viral RNA isolated from virus produced in transfected 293T
cells was used as the source of a primer tRNA annealed in vivo to
viral RNA in an in vitro reverse transcription reaction as previously
described (Huang et al., 1996). Brieﬂy, total viral RNA was
incubated at 37 °C for 15 min in 20 μl of RT buffer (50 mM Tris–
HCl (pH 7.5), 60 mM KCl, 3 mM MgCl2 and 10 mM dithiothreitol
(DTT)) containing 50 ng puriﬁed HIV RT, 10 U of RNasin and
various deoxynucleotide triphosphates (dNTPs). To measure the
ability of annealed tRNALys3 to be extended by six deoxyribonucleo-
tides, the RT reaction mixture contained 200 μM dCTP, 200 μM
dTTP, 5 μCi of [α-32P] dGTP (0.16 μM), and 50 μM ddATP. To
measure the ability of annealed tRNALys3 to be extended by one
deoxyribonucleotide, the RT reaction mixture contained only
0.16 μM α-32P-dCTP. Reaction products were resolved using one-
dimensional (1D) 6% polyacrylamide gel electrophoresis (PAGE)
containing 7 M urea (Huang et al., 1996).
Transient exposure of viral RNA to NCp7 involved exposing total
viral RNA for 30 min at 37 °C to 0, 4, or 10 pmol of NCp7.
Deproteinization was performed through the addition of 1 μl
proteinase K (5 mg/ml) to the reactions, which were incubated at
37 °C for 30min, followed by phenol/chloroform extraction to remove
both proteinase K and digested residual proteins. The viral RNA
complex was ethanol precipitated, dried, and used in the reverse
transcriptase reaction.
In vitro annealing of tRNALys3 to viral RNA
Human placental tRNALys3 was hybridized with synthetic HIV-1
viral genomic RNA, wild type or containing the 2R mutation. The
tRNALys3 was puriﬁed from human placenta as previously described
(Jiang et al., 1993), using standard chromatography procedures
(sequentially DEAE-Sephadex A-50, reverse-phase chromatography
(RPC-5), and Porex C4) and, ﬁnally, two dimensional polyacrylamide
gel electrophoresis (2D-PAGE). The wild type synthetic genomic RNA
(497 nt), comprising the complete R and U5 regions, the PBS, leader,
and part of the gag coding region, was synthesized as previously
described (Huang et al., 1996) from the AccI-linearized plasmid pHIV-
PBS (Arts et al., 1994) with the MEGA-script transcription system
(Ambion Inc.). The mutant genomic RNA containing the 2R mutation
was synthesized from a PCR ampliﬁed BH102R fragment with MEGA-
script transcription system (Ambion, Inc.). The forward PCR primer is
at the beginning of the R region in the LTR, and contains the
T7promoter at its 5-terminus: 5′-TAATACGACTCACTATAGGGT-
CTCTCTGGT TAGAC-3′. The reverse primer is located at N-terminalof the gag coding region: 5′-CAGCCT TCTGATGTTTCTAACAGG-3′. The
synthetic 2R mutant genomic RNA (504 nt) comprises the complete R
and U5 region, the PBS, the leader, and part of gag coding region.
tRNALys3 annealing to viral RNA was facilitated by either the
addition of NCp7 or GagΔp6 as previously described (Cen et al., 2000).
1 pmol of tRNALys3 was annealed to 1 pmol of synthetic HIV-1 RNA
template by incubating these reagents at 37 °C for 90 min with
30 pmol of NCp7 or GagΔp6 in a 10 μl reaction mixture containing
(50 mM Tris–HCl (pH 7.2), 50 mM KCl, 5 mMMgCl2, 10 mM DTT) and
10 U of RNasin.
tRNALys3 occupation of the PBS
A28ntDNAoligomer (5′-CCCCGCTTAATACTGACGCTCTCGCACC-3′)
was 5′-end-labeled with 32P using T4 kinase and was complemen-
tary to sequences in HIV-1 RNA genome 139 base downstream of the
PBS. The complex was then incubated at 37 °C for 30 min in 20 μl of
RT buffer (50 mM Tris–HCl (pH 7.5), 60 mM KCl, 3 mM MgCl2 and
10 mM DTT) containing 50 ng HIV RT, 10 U of RNasin, 200 μM
deoxynucleoside triphosphates, The reaction products, either full-
length (365 nt) or truncated (167 nt, due to occupation of the PBS
by tRNALys3), were resolved using 1D 6% PAGE with gels containing
7M Urea.
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